Phathom Pharmaceuticals, Inc. PHAT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$157.3M+54.5% | -$221.25M+33.8% | -$274.55M+19.1% | -$330.15M-11.1% | -$345.79M-40.2% | ||
| $566K-25.3% | $633K-20.4% | $698K-11.3% | $733K+2.2% | $758K+17.9% | ||
| $28.71M+19.8% | $28.72M+19.4% | $29.8M-29.0% | $26.13M-38.4% | $23.96M-45.0% | ||
| -$97.49M+65.5% | -$166.78M+37.5% | -$225.23M+8.9% | -$274.69M-27.5% | -$282.68M-69.3% | ||
| $272K+141% | $229K+69.6% | $147K-75.7% | $164K-89.1% | $113K-92.3% | ||
| -$272K-141% | -$229K-69.6% | -$147K+75.7% | -$164K+89.1% | -$113K+92.3% | ||
| $173.25M+250% | $0-100% | $24.75M-66.5% | $24.75M-66.5% | $49.5M+0.6% | ||
| —— | —— | —— | —— | —— | ||
| $66.35M-61.6% | -$288K-100% | $25.86M-93.0% | $148.18M-39.9% | $172.87M-52.4% | ||
| -$31.41M— | -$167.29M— | -$199.52M— | —— | —— | ||
| -$97.76M+65.4% | -$167M+37.4% | -$225.38M+9.0% | -$274.85M-26.7% | -$282.79M-67.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Phathom Pharmaceuticals, Inc. generate?
- Phathom Pharmaceuticals, Inc. (PHAT) generated -$97.5M in operating cash flow over the trailing twelve months.
- What is Phathom Pharmaceuticals, Inc.'s free cash flow?
- After $272.0K of capital expenditures, Phathom Pharmaceuticals, Inc.'s free cash flow was -$97.8M over the trailing twelve months, up 65.4% year over year.
- Where does Phathom Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Phathom Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
